Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
Orion Pharma's ODM-212 Granted Orphan Drug Designation in Mesothelioma by the US FDA
Orion Pharma's ODM-212 Granted Orphan Drug Designation in Mesothelioma by the US FDA Orion Corporation (Orion Pharma) today announced that its investigational drug ODM-212 has received Orphan Drug Designation (ODD) from the US Food and Drug…
Why 'Big Pharma' isn't cashing in on the peptide craze
The most popular peptides being bought illegally in Australia are yet to attract serious attention from big pharmaceutical companies, who believe they would not be lucrative or safe enough products to bring to the legitimate market. Injectable…
Nxera Pharma to Receive US$10 Million Milestone Payment from AbbVie under Collaboration Targeting Neurological Diseases
This marks the third milestone achieved under the collaboration and reflects the steady progress of the pipeline Under the terms of the agreement, Nxera is eligible to receive up to US$1.2 billion in potential option, development and commercial…
China's pharma dominance is just beginning
The old pharmaceutical order anchored around cutting-edge advances from the West has quietly disappeared. What we have now is a bipolar industry centred on the US and China – with implications for patients and policymakers worldwide. China…
Pharma exports rose 2% to over $31 billion in FY26 despite sharp decline in March
India's pharmaceutical exports rose more than 2% year on year to $31.11 billion in FY26 despite a 23% decline in March amid the fallout of the West Asia war. A new record, the exports bettered the $30.47 billion registered in 2024-25. March…
Cyprus pharma sector to expand global humanitarian outreach
Cyprus' Foreign Ministry, the Employers and Industrialists Federation (Oev) and the Pancyprian Pharmaceutical Manufacturers Association (Paef) recently signed a memorandum of cooperation to promote joint actions in humanitarian aid and development…
JAMP Pharma Group Strengthens Its Immunology Biosimilars Portfolio with PrUpgolyv™, a Golimumab Biosimilar that has Receive its Notice of Compliance by Health Canada.
Health Canada has authorized Upgolyv™, a golimumab injection biosimilar in Canada, reinforcing JAMP Pharma Group's leadership in the Canadian biosimilars market. This authorization expands BioJAMP's growing immunology biosimilars portfolio…
Urogen Pharma (NASDAQ:URGN) Given Average Recommendation of 'Moderate Buy' by Analysts
Urogen Pharma (NASDAQ:URGN - Get Free Report) has been given an average rating of 'Moderate Buy' by the nine research firms that are covering the firm, MarketBeat reports. One investment analyst has rated the stock with a sell rating, one has…
Over a dozen stocks, including UltraTech, Lupin, Aurobindo Pharma, EMS, Amagi Media, Zee, PC Jeweller, to remain in focus
UltraTech Cement Ltd, the cement flagship of the Aditya Birla Group, has announced that it will surpass 200+ million tonnes per annum (MTPA) of installed cement manufacturing capacity in India. The Company is set to commission three new cement…
Ascentage Pharma Group International (NASDAQ:AAPG) Shares Gap Down - What's Next?
Ascentage Pharma Group International - Unsponsored ADR (NASDAQ:AAPG - Get Free Report) shares gapped down before the market opened on Monday. The stock had previously closed at $27.40, but opened at $26.39. Ascentage Pharma Group International…
Why clinical trials are broken & how to fix them: a reading list - LessWrong
12 articles including 4 podcasts EA/LW Intro: I believe clinical trial abundance could be an EA cause area - there's still a lot of disability/disease burden in the world, even in developed countries, and increasing the pace of progress is very…
Industrial credit growth may clock 9-13% in H1CY26
A recent Ficci-IBA survey forecasts a steady 9-13 per cent industrial credit growth for the Indian banking sector in the first half of 2026, propelled by a revival in capital expenditure, significant infrastructure development, and a broad recovery…
Diagnostics Sector Q4 FY26 Outlook: Strong Revenue, Profit Growth Expected
The Indian diagnostics sector is poised for a robust performance in Q4FY26, with analysts forecasting significant revenue and profit growth, outshining its healthcare counterparts due to strong domestic demand and insulation from global…
Kalshi's fight over sports betting is hurtling towards the Supreme Court-and the future of gambling is at stake
Prediction markets Kalshi and Polymarket claim to be truth machines that offer insights into everything from elections to interest rates. But they are also something else: Massive sports betting platforms. Recent reports have found that sports…
ICON (ICLR) Q1 2025 Earnings Call Transcript
Thursday, May 1, 2025 at 8 a.m. ET Chief Executive Officer — Steve Cutler Chief Financial Officer — Nigel Clerkin Chief Operating Officer — Barry Balfe Vice President, Investor Relations — Kate Haven Revenue -- $2…
Receive a Daily briefing on Pharma Industry News
Get Started